½ÃÀ庸°í¼­
»óǰÄÚµå
1225673

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå : ½ÃÄö½Ì À¯Çüº°, Á¦Ç° À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ¿¹Ãø ºÐ¼®(2022-2028³â)

Global Next Generation Sequencing Market By type of secquencing, By product type, By end use, & By region-Forecast Analysis 2022-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â 2021³â 102¾ï 8,000¸¸ ´Þ·¯¿¡¼­ 2028³â¿¡´Â 337¾ï 3,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âºÎÅÍ 2028³â±îÁö ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 18.50%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì(Next Generation Sequencing) ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ±Ô¸ð, ½ÃÀå ¿ªÇÐ, ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

»óÀ§ ½ÃÀå ºÐ¼®

½ÃÀå °³¿ä

½ÃÀå ±Ô¸ð

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ±âȸ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °úÁ¦
  • SWOT ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀå »ýŰè
  • IP ºÐ¼®
  • ¹«¿ª ºÐ¼®
  • ½ºÅ¸Æ®¾÷ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥

½ÅÇü Äڷγª¹ÙÀÌ·¯½ºÀÇ ¿µÇâ

  • ¼­·Ð
  • °æÁ¦ ½Ã³ª¸®¿À Æò°¡¿¡ ´ëÇÑ ¿µÇâ
  • ¼öÁ¤µÈ ½ÃÀå ±Ô¸ð
  • COVID-19°¡ ÁÖ¿ä ºÎ¹®¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • COVID-19 Àü·« : ±â¾÷º°

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ±âȸ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °úÁ¦
  • ±ÔÁ¦ »óȲ
  • SWOT ºÐ¼®
  • Porter's Five Forces ºÐ¼®
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • ´ëüǰÀÇ À§Çù
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ÇâÈÄ È¥¶õ¿¡ °üÇÑ Skyquest Ưº° ÀλçÀÌÆ®
    • Á¤Ä¡Àû ¿µÇâ
    • °æÁ¦Àû ¿µÇâ
    • »çȸÀû ¿µÇâ
    • ±â¼úÀû ¿µÇâ
    • ȯ°æÀû ¿µÇâ
    • ¹ýÀû ¿µÇâ

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì : ±â¼úº°

  • ½ÃÀå ºÎ¹®
  • Wgs
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Àüü ¿¢¼Ø ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Ÿ°Ù ½ÃÄö½Ì ¹× ¸®½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • DNA ±â¹Ý
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • RNA ±â¹Ý
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì : ½ÃÄö½Ì À¯Çüº°

  • ½ÃÀå ºÎ¹®
  • Àüü °Ô³ð ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Ÿ°Ù ¸®½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Àüü ¿¢¼Ø ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • RNA ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Ĩ ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • De Novo Sequencing
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • ¸ÞÆ¿ ½ÃÄö½Ì
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)

¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì : Á¦Ç° À¯Çüº°

  • ½ÃÀå ºÎ¹®
  • Àåºñ
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • ½Ã¾à ¹× ¼Ò¸ðǰ
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • ¼­ºñ½º
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)

ÃÖÁ¾»ç¿ëÀÚº° ¼¼°èÀÇ Â÷¼¼´ë ½ÃÄö½Ì

  • ½ÃÀå ºÎ¹®
  • º´¿ø¡¤ÀÇ·á±â°ü
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Çмú±â°ü
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)
  • Á¦¾à ±â¾÷ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø(2021-2028³â)

½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

ÁÖ¿ä ±â¾÷ °³¿ä

  • °æÀï ±¸µµ
  • Agilent Technologies
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.
LSH 23.03.13

Global Next Generation Sequencing Market was valued at USD 10.28 Billion in 2021, and it is expected to reach a value of USD 33.73 Billion by 2028, at a CAGR of 18.50% over the forecast period (2022- 2028).

The term "NGS" refers to the extensive DNA sequencing techniques that support genomic research.

A wide range of reputable pharmaceutical and biotechnology businesses have agreed to step up to support the global research efforts to create test kits and vaccinations in the wake of the World Health Organization's (WHO) declaration of COVID-19 as a pandemic.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global next generation sequencing market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global next generation sequencing market is segmented on the basis of type of sequencing, product type, end-user, and region. Based on the type of sequencing, the market is segmented into Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, Chip Sequencing, De Novo Sequencing, and Methyl Sequencing. Based on the product type, the market is segmented into instruments, reagents & consumables, and services. Based on the end-user, the market is segmented into hospitals and healthcare institutions, academic institutes and research centers, and pharmaceutical and biotechnology companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Driver

Major corporations now have more capacities for research and development. The development of the COVID-19 vaccine was given a lot of attention, which created a lucrative potential for the use of NGS during the pandemic. For the sequencing of COVID-19 samples, a team of researchers in China used Oxford Nanopore Technologies' (U.K.) MinION Mk1C product. A favourable environment for market expansion is also anticipated to be provided by factors like the widespread use of NGS technologies in clinical diagnostics because of their quick turnaround times and expedited processing throughout the forecast period. For instance, in August 2020, Pediatrix Medical Group, GeneDx Inc., and OPKO Health struck a contract to offer cutting-edge, next-generation gene-sequencing to newborn critical care units to improve clinical diagnosis of rare illnesses.

Restraint

Lack of skilled workers will hinder the market growth during the forecast period. Legal and ethical restrictions will further restrain the market growth and create challenges for players in the market.

Market Trends

In the upcoming years, NGS instruments and technologies are expected to have significant market expansion due to increased technical advancements. For instance, the Harvard University, DNA Script, and Broad Institute received a USD 23 million grant from the Intelligence Advanced Research Projects Activity in the U.S. in January 2020. The institutes are working together to develop a cutting-edge technology that will incorporate NGS and enzymatic DNA synthesis into a single device.

Table of Contents

Executive Summary

Market overview

  • Exhibit: Executive Summary - Chart on Market Overview
  • Exhibit: Executive Summary - Data Table on Market Overview
  • Exhibit: Executive Summary - Chart on Global Next Generation Sequencing Characteristics
  • Exhibit: Executive Summary - Chart on Market by Geography
  • Exhibit: Executive Summary - Chart on Market Segmentation
  • Exhibit: Executive Summary - Chart on Incremental Growth
  • Exhibit: Executive Summary - Data Table on Incremental Growth
  • Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy-scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Next Generation Sequencing size and forecast 2022-2028 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2022-2028 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
  • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
  • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
  • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
  • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
  • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact
  • Global Next Generation Sequencing by Technology
  • Market segments
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Data table on Market share 2022-2028 (%)
  • Wgs
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Whole Exome Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Targeted Sequencing & Resequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Dna-Based
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Rna-Based
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Global Next Generation Sequencing by Type Of Sequencing
  • Market segments
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Data table on Market share 2022-2028 (%)
  • Whole Genome Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Targeted Resequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Whole Exome Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Rna Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Chip Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • De Novo Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Methyl Sequencing
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Global Next Generation Sequencing by Product Type
  • Market segments
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Data table on Market share 2022-2028 (%)
  • Instruments
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Reagents And Consumables
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Services
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Global Next Generation Sequencing by End User
  • Market segments
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Data table on Market share 2022-2028 (%)
  • Hospitals And Healthcare Institutions
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Academics
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Pharmaceutical And Biotechnology Companies
    • Market Estimates & Forecast, 2021-2028
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)

Market Size by Region

  • Chart on Market share by geography 2022-2028 (%)
  • Data Table on Market share by geography 2022-2028(%)
  • North America
    • Chart on Market share by country 2022-2028 (%)
    • Data Table on Market share by country 2022-2028(%)
    • USA
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Canada
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Europe
    • Chart on Market share by country 2022-2028 (%)
    • Data Table on Market share by country 2022-2028(%)
    • Germany
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Spain
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • France
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • UK
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Rest of Europe
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2022-2028 (%)
    • Data Table on Market share by country 2022-2028(%)
    • China
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • India
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Japan
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • South Korea
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Rest of Asia Pacific
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Latin America
    • Chart on Market share by country 2022-2028 (%)
    • Data Table on Market share by country 2022-2028(%)
    • Brazil
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Rest of South America
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2022-2028 (%)
    • Data Table on Market share by country 2022-2028(%)
    • GCC Countries
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • South Africa
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)
    • Rest of MEA
  • Exhibit: Chart on Market share 2022-2028 (%)
  • Exhibit: Market size and forecast 2022-2028 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
  • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
  • Exhibit: company positioning matrix, 2021
    • Top companies market Share
  • Exhibit: Pie chart analysis on company market share, 2021(%)
  • Agilent Technologies
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • F. Hoffmann-La Roche Ltd
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Illumina Inc.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • PerkinElmer Inc.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
  • Thermo Fisher Scientific Inc.
    • Exhibit Company Overview
    • Exhibit Business Segment Overview
    • Exhibit Financial Updates
    • Exhibit Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦